Novartis Investigative Site

Luton, Beds LU4 0DZ

0 studies enrolling now · 3 studies all time

What they study most

Primary Prevention of Atherosclerotic Cardiovascular Disease, Relapsing Multiple Scelrosis, Relapsing Multiple Sclerosis

Studies at this site

• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS — Running, not enrolling
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. — Completed